View Older Stories

Mar 30, 2026 05:42PM William Blair Upgrades 10X Genomics (TXG) to Outperform

Mar 25, 2026 07:01AM Bioptimus launches STELA spatial biology atlas with 10x Genomics partnership

Mar 17, 2026 08:56AM TD Cowen: 'MSFT's AI-Powered Spatial Product Weakens Spatial Exposed Stocks'

Mar 2, 2026 09:04AM 10X Genomics (TXG) PT Raised to $25 at Stifel on Solid New Product Adoption

Feb 13, 2026 09:00AM 10X Genomics (TXG) PT Raised to $22 at Canaccord Genuity

Feb 12, 2026 04:12PM 10x Genomics (TXG) Tops Q4 EPS by 9c, provides guidance

Feb 4, 2026 09:03AM 10x Genomics partners with UK consortium for cancer research

Jan 27, 2026 06:22AM 10X Genomics (TXG) PT Lowered to $20 at Leerink Partners

Jan 12, 2026 09:12AM 10x Genomics partners with Brigham & Women's for autoimmune study

Jan 12, 2026 09:10AM 10x Genomics partners with Dana-Farber for cancer diagnostics research

Jan 12, 2026 04:20AM 10X Genomics (TXG) PT Raised to $21 at BofA Securities

Jan 7, 2026 07:10AM CareDx partners with 10x Genomics on transplant rejection research program

Dec 1, 2025 04:24PM Morgan Stanley Assumes 10X Genomics (TXG) at Equalweight Citing Reasonable Valuation

Nov 14, 2025 06:11AM 10x Genomics names Randy Wu as general counsel, Eric Whitaker retires

Nov 6, 2025 04:35PM 10x Genomics (TXG) Tops Q3 EPS by 7c, Beats on Revenue; Offers Q4 Revenue Guidance

Oct 29, 2025 09:01AM 10x Genomics launches enhanced Chromium Flex assay for single cell research

Oct 20, 2025 12:31PM 10x Genomics partners with Anthropic to integrate analysis tools into Claude

Sep 11, 2025 03:49AM Piper Sandler Starts 10X Genomics (TXG) at Neutral

Aug 19, 2025 09:02AM 10x Genomics launches Xenium Protein for RNA and protein analysis

Aug 7, 2025 04:28PM 10x Genomics (TXG) Tops Q2 EPS by 65c, provides guidance

Jul 1, 2025 06:40AM Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)

May 27, 2025 08:00PM Citi names 3 stocks as its new top picks in the Life Science sector

May 14, 2025 04:05PM 10x Genomics (TXG) Announces Patent Litigation Settlement Agreement with Bruker

May 12, 2025 05:24AM 10X Genomics (TXG) PT Lowered to $15 at Canaccord Genuity

May 8, 2025 04:12PM 10x Genomics (TXG) Tops Q1 EPS by 19c, provides guidance

Mar 3, 2025 04:13PM 10x Genomics (TXG) Secures Injunction Against Parse Biosciences' Planned ATAC Products

Feb 26, 2025 02:46PM 10x Genomics (TXG) 999 contracts of August 17.50 calls trade

Feb 13, 2025 06:40AM 10X Genomics (TXG) PT Lowered to $20 at Citi

Feb 13, 2025 06:37AM 10X Genomics (TXG) PT Lowered to $18 at Canaccord Genuity

Feb 12, 2025 04:14PM 10x Genomics (TXG) Misses Q4 EPS by 9c, provides guidance

Jan 13, 2025 08:48AM 10x Genomics (TXG) Announces Preliminary Select Fourth Quarter and Full Year 2024 Results

Dec 23, 2024 04:06PM U.S. District Court Awards 10x Genomics (TXG) Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

Oct 30, 2024 06:20AM Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)

Oct 29, 2024 04:12PM 10x Genomics (TXG) Tops Q3 EPS by 4c, Misses on Revenue; Offers FY24 Revenue Guidance

Oct 16, 2024 08:27AM TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)

Oct 10, 2024 08:22AM TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)

Oct 10, 2024 06:17AM 10X Genomics (TXG) PT Lowered to $20 at Canaccord Genuity

Oct 10, 2024 05:51AM Citi Reiterates Buy Rating on 10X Genomics (TXG)

Oct 10, 2024 05:32AM BofA Securities Reiterates Neutral Rating on 10X Genomics (TXG)

Oct 9, 2024 04:44PM After-hours movers: 10x Genomics, AZZ, Inc., Applied Digital, and more

Oct 9, 2024 04:08PM 10x Genomics (TXG) sees revenue of approximately $151.7 million for the third quarter

Oct 2, 2024 08:48AM TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)

Sep 4, 2024 06:54AM Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)

Aug 13, 2024 05:57AM 10X Genomics (TXG) PT Lowered to $46 at Morgan Stanley

Aug 8, 2024 04:07PM 10x Genomics (TXG) Announces Leadership Changes

Jul 23, 2024 06:22AM 10X Genomics (TXG) PT Lowered to $32 at Canaccord Genuity

Jul 22, 2024 04:30AM Jefferies Upgrades 10X Genomics (TXG) to Buy

Jul 18, 2024 05:34AM JPMorgan Downgrades 10X Genomics (TXG) to Neutral

Jul 16, 2024 05:11AM 10X Genomics (TXG) PT Lowered to $25 at Stifel

Jul 15, 2024 02:00PM Life Science Tools & Diagnostics stocks: Q2 earnings preview

View Older Stories